IM Cannabis Stock (NASDAQ:IMCC)


OwnershipChart

Previous Close

$0.16

52W Range

$0.15 - $3.75

50D Avg

$0.28

200D Avg

$1.08

Market Cap

$494.60K

Avg Vol (3M)

$4.25M

Beta

1.98

Div Yield

-

IMCC Company Profile


IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

IL

Employees

95

IPO Date

May 20, 2020

Website

IMCC Performance


Latest Earnings Call Transcripts


Q1 25May 15, 25 | 9:00 AM
Q4 24Mar 31, 25 | 9:00 AM
Q3 24Nov 14, 24 | 9:00 AM

Peer Comparison


TickerCompany
AKANAkanda Corp.
SHPHShuttle Pharmaceuticals Holdings, Inc.
VEROVenus Concept Inc.
GRIGRI Bio, Inc.
JAGXJaguar Health, Inc.
NAOVNanoVibronix, Inc.
FLGCFlora Growth Corp.
NDRAENDRA Life Sciences Inc.
MOVECorvex, Inc.
RDHLRedHill Biopharma Ltd.